Skip to main content

Want a detailed portfolio tracker?

Pulmatrix (PULM) P/E (2015 - 2026)

Pulmatrix (PULM) P/E from Jun 30, 2015 to Jun 3, 2026. The TTM Pulmatrix (PULM) P/E is -1.04. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Pulmatrix (PULM)

YearP/EChange
2026-1.04-33.98%
2025-1.58-40.92%
2024-2.67+538.87%
2023-0.42-40.89%
2022-0.71-43.63%
2021-1.25-30.42%
2020-1.80+197.68%
2019-0.60-8.34%
2018-0.66-81.76%
2017-3.62+273.33%
2016-0.97-84.68%
2015-6.33N/A

Comparison Pulmatrix (PULM) P/E with competitors

Pulmatrix (PULM) P/E is -1.04.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.16%
NBYStablecoin Development Corp0.10-109.83%
ENLVEnlivex Therapeutics Ltd0.15-114.44%
FGENFibroGen Inc0.24-123.08%
TRAWTraws Pharma Inc0.47-145.46%
FBIOFortress Biotech Inc0.71-167.88%
CHRSCoherus Biosciences Inc0.98-194.04%
ORMPOramed Pharmaceuticals Inc1.47-241.67%
AGENAgenus Inc2.05-296.95%
VIVSVivoSim Labs Inc2.54-343.80%
INVAInnoviva Inc3.19-406.56%
CRMDCorMedix Inc3.65-450.52%
ABEOAbeona Therapeutics Inc4.20-504.30%
VXRTVaxart Inc4.26-509.74%
CVACCureVac N.V.4.45-527.43%
SRPTSarepta Therapeutics Inc4.62-544.60%
GLPGGalapagos NV4.86-567.16%
RIGLRigel Pharmaceuticals4.92-572.99%
ZVRAZevra Therapeutics Inc4.97-578.23%
ABUSArbutus Biopharma Corp5.69-647.43%
CGENCompugen Ltd7.38-809.94%
AUPHAurinia Pharmaceuticals Inc9.25-989.50%
ACADAcadia Pharmaceuticals Inc9.59-1021.87%
OMEROmeros Corporation9.88-1050.27%
PLXProtalix BioTherapeutics Inc9.91-1052.74%
SPROSpero Therapeutics Inc10.73-1132.12%
ADMAAdma Biologics Inc11.33-1189.41%
SVASinovac Biotech Ltd11.44-1199.55%
TBPHTheravance Biopharma Inc11.78-1232.30%
HRMYHarmony Biosciences Holdings Inc12.18-1271.12%
TGTXTG Therapeutics Inc13.18-1367.17%
INCYIncyte Corp13.38-1386.65%
SABSSAB Biotherapeutics Inc14.06-1451.62%
XOMAXOMA Corp14.95-1536.95%
REGNRegeneron Pharmaceuticals Inc14.98-1540.32%
PBYIPuma Biotechnology Inc15.05-1547.07%
EXELExelixis Inc15.79-1618.64%
NAGENiagen Bioscience Inc16.35-1672.49%
CPRXCatalyst Pharmaceuticals Inc17.34-1767.66%
MDXGMimedx Group Inc17.38-1770.60%
ARGXArgen X SE23.07-2318.29%
HALOHalozyme Therapeutics Inc23.20-2330.69%
XOMAOXOMA Corp25.34-2536.85%
VRTXVertex Pharmaceuticals Inc25.66-2566.75%
XOMAPXOMA Corp25.67-2568.13%
CTMXCytomX Therapeutics Inc25.70-2570.80%
ASNDAscendis Pharma A/S26.35-2633.90%
RPRXRoyalty Pharma plc - Class A27.50-2743.63%
SLNOSoleno Therapeutics Inc29.02-2889.77%
LGNDLigand Pharmaceuticals Inc - Class B30.19-3002.38%
BMRNBiomarin Pharmaceutical Inc37.51-3706.25%
APLSApellis Pharmaceuticals Inc39.02-3851.81%
KRYSKrystal Biotech Inc39.70-3916.85%
GMABGenmab40.20-3965.50%
ONCBeiGene Ltd67.03-6544.52%
TECHBio-Techne Corp68.59-6695.29%
VCELVericel Corp80.63-7852.35%
PHARPharming Group N.V.87.74-8536.06%
ALNYAlnylam Pharmaceuticals Inc124.93-12112.15%
TLXTelix Pharmaceuticals Ltd139.89-13550.24%
CORTCorcept Therapeutics Inc158.39-15328.84%